Mundipharma: Neoplasms trials
The registry lists 11 Neoplasms studies with Mundipharma as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 2 1Phase 3 2Phase 4 5No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Analgesic Treatment for Cancer Pain in South East AsiaCompletedNCT02664987Results posted
- Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer PainCompletedNCT01885182Phase 3Results posted
- PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer PainCompletedNCT01719757Phase 4Results posted
- Immediate-Release Oxycodone Capsules Study in Cancer PainCompletedNCT01675622Phase 3Results posted
- A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)CompletedNCT01675531Phase 4Results posted
- A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer PatientsCompletedNCT01313780Phase 4Results posted
- Safety and Effectiveness of Transdermal Buprenorphine in Cancer PainCompletedNCT04315831
- A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer PainCompletedNCT03176199Phase 4
- Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer PainCompletedNCT03176121Phase 4
- Effect of Good Pain Management (GPM) Ward Program on Moderate to Severe Cancer Pain PatientsStatus unknownNCT03155516Not applicable
- A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer PainCompletedNCT00513656Phase 2